Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Carr, A
People taking the most common GLP-1 drugs lost an average of 33 pounds while on treatment, but gained back about 22 pounds within a year of stopping, study co-author Sam West told The Washington Post
Phase 2 data is promising
For retatrutide at 4,895 daltons, these comparisons suggest that nasal delivery is feasible but will require optimization, that brain delivery effects may be achievable at doses lower than needed for full systemic effect, and that absorption variability will be higher than with injection
US$ 20.05
US$ 29.18
US$ 22.95
US$ 29.14
US$ 23.45
